Literature DB >> 14988703

Leukotriene receptor antagonists are ineffective for severe atopic dermatitis.

Nanette B Silverberg, Amy S Paller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14988703     DOI： 10.1016/s0190-9622(03)00758-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.

Authors:  Eustachio Nettis; Maddalena D'Erasmo; Elisabetta Di Leo; Gianfranco Calogiuri; Vincenzo Montinaro; Antonio Ferrannini; Angelo Vacca
Journal:  Mediators Inflamm       Date:  2010-09-22       Impact factor: 4.711

Review 2.  Emerging treatment of atopic dermatitis.

Authors:  Chih-Jung Hsu; Li-Fang Wang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

3.  A systematic review on the off-label use of montelukast in atopic dermatitis treatment.

Authors:  Weng Khong Chin; Shaun Wen Huey Lee
Journal:  Int J Clin Pharm       Date:  2018-05-18

4.  Montelukast does not inhibit the late phase reaction in Parthenium dermatitis.

Authors:  Lakshmi Chembolli; C R Srinivas
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

5.  A Double-Blind, Randomized, Crossover Study to Compare the Effectiveness of Montelukast on Atopic Dermatitis in Korean Children.

Authors:  You Hoon Jeon; Taek Ki Min; Hyeon Jong Yang; Bok Yang Pyun
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.